mRNA biomarkers sensitive and specific to micro‐dose erythropoietin treatment at sea level and altitude
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3665 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Francesco Loria und 7 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Laboratory for Doping Analyses, University Center of Legal Medicine, Lausanne & Geneva, Lausanne University Hospital & University of Lausanne, …. Hauptthemen laut MEDLINE: Altitude, Doping in Sports, Biomarkers, 5-Aminolevulinate Synthetase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: World Anti-Doping Agency, International Olympic Committee, China Anti-Doping Agency.
Abstract (Originalsprache)
Recombinant human erythropoietin (rhEPO) is prohibited by the World Anti‐Doping Agency. rhEPO abuse can be indirectly detected via the athlete biological passport (ABP). However, altitude exposure challenges interpretation of the ABP. This study investigated whether 5′‐aminolevulinate synthase 2 ( ALAS2 ) and carbonic anhydrase 1 ( CA1 ) in capillary dried blood spots (DBSs) are sensitive and specific markers of rhEPO treatment at altitude. ALAS2 and CA1 expression was monitored in DBS collected weekly before, during, and after a 3‐week period at sea level or altitude. Participants were randomly assigned to receive 20 IU kg bw −1 epoetin alpha (rhEPO) or placebo injections every second day for 3 weeks while staying at sea level (rhEPO, n = 25; placebo, n = 9) or altitude (rhEPO, n = 12; placebo, n = 27). ALAS2 and CA1 expression increased up to 300% and 200%, respectively, upon rhEPO treatment at sea‐level and altitude ( P ‐values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Swiss Laboratory for Doping Analyses, University Center of Legal Medicine, Lausanne & Geneva, Lausanne University Hospital & University of Lausanne, Lausanne, Switzerland.
- Department of Public Health, Research Unit for Exercise Biology, Aarhus University, Aarhus, Denmark.
- Department of Nutrition, Exercise and Sports (NEXS), University of Copenhagen, Copenhagen, Denmark.
- University Center of Legal Medicine, Lausanne & Geneva, Lausanne University Hospital & University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Jacob Bejder, Nicolas Leuenberger, Nikolai Baastrup Nordsborg
Förderung
- World Anti-Doping Agency
- International Olympic Committee
- China Anti-Doping Agency
- International Testing Agency
- U.S. Anti-Doping Agency
- Anti-doping Switzerland
- Sport Integrity Australia
- Japan Anti-Doping Agency
Zitieren
APA
Loria, F., Breenfeldt Andersen, A., Bejder, J., Bonne, T., Grabherr, S., Kuuranne, T., Leuenberger, N., & Baastrup Nordsborg, N. (2024). mRNA biomarkers sensitive and specific to micro‐dose erythropoietin treatment at sea level and altitude. Drug Testing and Analysis. https://doi.org/10.1002/dta.3665
Vancouver
Loria F, Breenfeldt Andersen A, Bejder J, Bonne T, Grabherr S, Kuuranne T, et al. mRNA biomarkers sensitive and specific to micro‐dose erythropoietin treatment at sea level and altitude. Drug Testing and Analysis. 2024. doi:10.1002/dta.3665
BibTeX
@article{Loria2024,
author = {Loria, Francesco and Breenfeldt Andersen, Andreas and Bejder, Jacob and Bonne, Thomas and Grabherr, Silke and Kuuranne, Tiia and Leuenberger, Nicolas and Baastrup Nordsborg, Nikolai},
title = {mRNA biomarkers sensitive and specific to micro‐dose erythropoietin treatment at sea level and altitude},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3665}
}
EUVIMED